Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis

Abstract

During the luteal phase, both ki-67 and bcl-2 expression is reduced in adenomyotic lesions in a similar way to that occurring in patients using Mirena. Oral contraceptives, on the other hand, do not affect bcl-2 expression in adenomyosis.